<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//trueconsulting.co/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://trueconsulting.co/briefing-es/colombia-ya-alcanzo-su-cenit-poblacional-y-no-esta-en-la-conversacion-publica.html</loc>
		<lastmod>2026-04-07T17:03:54+00:00</lastmod>
		<image:image>
			<image:loc>https://trueconsulting.co/wp-content/uploads/2026/04/image-3.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/por-que-el-precio-no-es-el-costo.html</loc>
		<lastmod>2026-06-05T00:11:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/la-paradoja-de-la-supervivencia-cuando-vivir-mas-tiempo-cambia-la-economia-del-cancer-de-mama.html</loc>
		<lastmod>2026-06-16T12:38:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/que-significa-realmente-que-una-tecnologia-sea-costo-efectiva.html</loc>
		<lastmod>2026-06-23T13:08:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/debe-valer-lo-mismo-un-qaly-en-todas-las-enfermedades.html</loc>
		<lastmod>2026-07-03T01:07:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/por-que-prevenir-puede-ser-mas-dificil-de-financiar-que-tratar.html</loc>
		<lastmod>2026-07-07T13:49:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/enfermedades-raras-parte-1-de-3-las-enfermedades-raras-realmente-son-tan-raras.html</loc>
		<lastmod>2026-07-14T12:26:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/enfermedades-raras-parte-2-de-3por-que-fue-necesario-crear-los-medicamentos-huerfanos.html</loc>
		<lastmod>2026-07-25T13:34:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/especial-true-briefings-enfermedades-raras-parte-3-de-3-es-justo-evaluar-igual-lo-que-es-diferente.html</loc>
		<lastmod>2026-07-28T12:29:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/cuanto-cuesta-no-adoptar-una-innovacion.html</loc>
		<lastmod>2026-08-04T16:59:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/debe-utilizarse-el-mismo-umbral-de-disponibilidad-a-pagar-para-todas-las-enfermedades.html</loc>
		<lastmod>2026-08-13T02:54:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/que-aprendimos-realmente-del-caso-wakefield.html</loc>
		<lastmod>2026-08-17T23:39:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/es-mayor-el-valor-de-una-vacuna-cuando-nacen-menos-ninos.html</loc>
		<lastmod>2026-08-25T01:18:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/una-ventaja-terapeutica-sigue-siendo-una-ventaja-si-al-paciente-no-le-importa.html</loc>
		<lastmod>2026-09-01T01:53:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://trueconsulting.co/briefing-es/cuando-el-exito-clinico-crea-nuevos-desafios-financieros.html</loc>
		<lastmod>2026-09-08T11:09:44+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->